James R. Margolis, MD
Promedica International is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Promedica International designates this educational activity for a maximum of 24.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. DVDs 1-12 are each designed for two category 1 credits; DVD 13 is designated for .75 category 1 credit. The time necessary to complete the series is 24.75 hours. The time necessary to complete DVDs 1-12 is two hours each; the time necessary to complete DVD 13 is .75 hours.
AMA PRA Category 1 Credits™ for these programs may be claimed until June 30, 2011.
All DVD course participants are required to take a test in order to be awarded credit. (Exam materials, if ordered, will be sent with your DVD order). All DVD course participants will also have the opportunity to critically evaluate the program as it relates to practice relevance and educational objectives.
Promedica International DVD teaching sessions feature a distinctive Studio Enhancement. The diagnostic images utilized by the faculty for each lecture are reproduced and studio-processed to optimize the display of anatomy and pathology. Each of the teaching slides are integrated into the program. The editing process ensures the DVD user the best image quality possible when viewing he diagnostic material. An electronic pointer is included to further reinforce the learning process. This DVD teaching program has been produced using broadcast quality digital equipment and editing techniques. All programs are reproduced from digital masters for maximum quality.
If you are not satisfied with your purchase, you may return your purchase (or any portion of your purchase) within 15 days of receiving it. You will receive a refund for the portion that is returned, less a $65.00 fee ($50.00 processing fee and a $15.00 standard shipping charge). If you are returning/cancelling multiple DVD series, please note the $65.00 fee applies to each series. If your purchase was sent express, the additional shipping charges will NOT be refunded. No refunds can be made after 15 days. All cancellations must be in writing. CME credit cannot be granted on the portion of the purchase that is returned.
Program 1
Spanish Session
Antiplatelet and Anticoagulant Therapy in Patients with Atrial Fibrillation: Who Underwent PCI with Stenting
Juan Miguel Ruiz-Nodar, MD
Intravascular Ultrasound Findings in Complications After DES Implantation
Fernando Alfonso, MD, PhD
Risk Score for Left Main Percutaneous Coronary Intervention
Angel Cequier, MD, PhD
On-Site Immediate Removal of Intra-aortic Balloon Pump with a 6 F Closure Suture Device with the "Preclosure" Technique
César Morís, MD
American Session I:
Washington Hospital Center Symposium
Contribution of IVUS in the DES Era
August D. Pichard, MD
Comparison of Long-term Outcomes in Patients Receiving Cypher Stents vs. Patients Receiving Taxus Stents: The REWARDS Registry
Augusto D. Pichard, MD
SOLACI Session: Revealing the Future of Coronary, Carotid and Structural Heart Devices
New FIM from South America
Alexandre Abizaid, MD, PhD
New Devices and Techniques to Close or Create Septal Defects
Carlos A.C. Pedra, MD
American Session II:
Mid-America Heart Institute Symposium
Chronic Total Occlusions: Is it Worth the Effort?
Barry D. Rutherford, MD
CTO-PCI: National Practice Patterns
J. Aaron Grantham, MD
top
Program 2
American Session II (continued)
Diabetic Plaque: What is New with an Age-Old Problem?
Steven P. Marso, MD
Percutaneous Lower Extremity Revascularization: What are we Really Doing?
David Safley, MD
Primary PCI: The Right Way
Barry D. Rutherford, MD
Left Atrial Appendage (LAA): To Close or Not to Close
Kenneth Huber, MD
Mini-Symposium on Mitral Regurgitation
Developing a New Generation of Stents and Delivery Devices for Small Vessel Cardiovascular and Neurological Disease
Carl Simpson, MD
Is it Useful to Treat Secondary Mitral Regurgitation (FMR)?
Andrew S. Wechsler, MD
Percutaneous Treatments for Functional Mitral Regurgitation
Richard R. Heuser, MD
Transpericardial LV Chamber and Annulus Therapy: Myocor iCoapsys
Wesley Pedersen, MD
Relative Risk for Death Post MI
Andrew S. Wechsler, MD
Central/Eastern European Session I:
"In Search of Lost Time": How to Improve the Outcome of Intervention for Acute Myocardial Infarct
How to Shorten the Time to Intervention in AMI Patients
Pawel Buszman, MD
top
Program 3
Central/Eastern European Session I (continued)
Pharmaco-mechanical Interventions for AMI: The CARESS, Eurotransfer Data and Subanalyses
Dariusz Dudek, MD, PhD
Cornary Aspiration in Patients with STEMI and Thrombus
Marko Noc, MD, PhD
Aspiration Thrombectomy before Stenting - New Way for Primary PCI: The PIHRATE Trial
Dariusz Dudek, MD, PhD
VH Analysis of Infarct Related Artery Before and After Stenting
Marcin Wizimirski, MD
Selected CXCR4 Cells for STEMI
Wojciech Wojakowski, MD
Bone Marrow Stem CElls Transplantation for the Treatment of Patients after Acute Myocardial Infarction: Single Centre Experience
Maciej Lesiak, MD, PhD
Urgent Coronary Angiography and PCI in Every Patient with Aborted Sudden Cardiac Death
Marko Noc, MD, PhD
Unprotected Left Main Stenting: LE MANS Registry, POLEMICA Registry
Pawel Buszman, MD
When Does Provisional T-stenting Provide Good Outcome after PCI of LM Bifurcation: QCA, ICUS, Virtual Histology Analysis
Dariusz Dudek, MD, PhD
CABG or PCI for LMCA?
Andrzej Bochenek, MD, PhD
PCI in Elderly Patients
Leszek Bryniarski, MD, PhD
top
Program 4
Australia/New Zealand Session
Apical Ballooning – Disease Spectrum and Long-term Follow-Up
Patrick Kay, MD
HEADROOM TRIAL Results of 1st 100 Patients
Mark Pitney, MD
Trends in Treatment and Long-Term Survival After Myocardial Infarction
John Elliott, MD
Variations in the Application of Cardiac Care in Australia: Factors Influencing Referral for Revascularization
Darren Walters, MD
Clinical Characteristics and Early Mortality of Patients Undergoing CABG Compared to PCI – Insights From Two Large Multi-centre Registries
David Clark, MD
Long Term Outcomes to 9 years for Percutaneous Septal Occluder Devices
Darren Walters, MD
American Session III:
Mayo Clinic Symposium
Historical Aspects of PCI: A Retrospective of the Last Thirty Years
David R. Holmes, MD
IVUS VH and Endothelial Dysfunction
Amir Lerman, MD
Adenosine Polymorphism: Relationships to Syndrome X and Acute MI
Amir Lerman, MD
Geometric Mitral Reconstruction for Ischemia and Cardiomyopathy
Steven F. Bolling, MD
“Cool It”- Therapeutic Hypothermia: The Miracle On Ice
Michael Mooney, MD
top
Program 5
American Session III (continued)
Balloon Aortic Valvuloplasty: Current Indications, Techniques and Clinical Outcomes
Wesley Pedersen, MD
Central/Eastern European Session II
Percutaneous Coronary Intervention for Acute Coronary Syndromes in Centers with and without Onsite Cardiac Surgery: Analysis from PL-ACS Registry
Adam Witkowski, MD
Multi-vessel Coronary Artery Disease in Patients With Compromised LV Function: Multidisciplinary Approach
Andrejz Bochenek, MD, PhD
Are Drug-Eluting Stents (Paclitaxel) Anti-Inflammatory?
Andrzej Ochala, MD
Quantitative Prediction of Side Branch Compromise: The Concept of Carina Displacement
Robert Gil, MD, PhD
Long-term Follow-Up of 100 Patients Treated with FRONTIER™, a Bifurcation Dedicated Stent: Single Centre Experience
Maciej Lesiak, MD
MVP for Moderate and Severe Mitral Stenosis Early Results and 3 Year Follow-Up in 400 Patients
Alexander Doganov, MD
American Session IV:
Columbia Symposium
Having the COURAGE to Advocate an Aggressive PCI Strategy
Jeffrey W. Moses, MD
Second Generation DES Systems: Are We Making Progress in Preventing Late Thrombosis?
Martin B. Leon, MD
top
Program 6
French Session
CTO: Japanese Techniques in a French Cath Lab?
Thierry Lefèvre, MD
Stent Boost in Routine Practice
Philippe Brunel, MD
Update in Trans-catheter Aortic Valve Replacement
Helene Eltchaninoff, MD
Long-Term Follow-Up After Left Main Stenting
Oliver Darremont, MD
Unprotected Left Main Stenting with DES: Complete Two-Year Clinical Follow-Up
Jean Fajadet, MD
Place of MSCT in the Follow-Up of Left Main Stenting Procedure
Martine Gilard, MD
Swiss Session
Radiation Protection in the Cath Lab: It Works if You Use It
Hans Rickli, MD
Update From BASKET: Are Drug-Eluting Stents Good for All Patients?,br>H.P. Brunner-La Rocca, MD
10-year Follow-Up of the SIMA Trial (Surgery Versus Stent for Proximal LAD Stenosis
Jean-Christophe Stauffer, MD
Findings in Left Main
Michael Pieper, MD
Non-Invasive Coronary Plaque Evaluation: The Interventionalist Point of View
Giovanni Pedrazzini, MD
top
Program 7
Transcatheter Aortic Valve Therapy: Status Update on the Global PARTNER Trial
Martin B. Leon, MD
Scandinavian Session
The Role of IVUS in Treatment of Bifurcation Lesions
M. Pauliina Margolis, MD
Age in Relation to Long-term Outcome After Primary PCI vs. Fibrinolysis: A DANAMI-2
Kari Saunamaki, MD
Scintigraphic Evaluation of the Effect of Distal Protection in Primary PCI: A DEDICATION Substudy
Anne Kaltoft, MD, PhD
Routine Primary PCI in 1,019 consecutive STEMI-patients - From Clinical Trial to Real-life Experience
Sune Pedersen, MD
The Nordic Bifurcation Studies - an Update - On Behalf of the Nordic-Baltic Bifurcation Study Group
Jens Flensted Lassen, MD, PhD
Insight of IVUS Findings from Nordic I Bifurcation Trial
Andrejs Erglis, MD, PhD
Coronary Angioplasty in Drug Eluting Stent Era for the Treatment of Unprotected Left Main Stenosis Compared to Coronary Artery Bypass Grafting: Northern Finland Registry
Hannu Romppanen, MD
Heart Center Concept: Collaboration with the Surgeons – For the Best of the Patient
Kari Niemelä, MD, PhD
Efficacy and Safety of Intracoronary Injection of Mono Nuclear Bone Marrow Cells After Thrombolytic Therapy of Acute Myocardial Infarction During 6-Month Follow-Up
Matti Niemelä, MD
Regenerative Potential of Cardiac Stem Cells
Mika Laine, MD
top
Program 8
Peripheral Session I:
Aortic and Iliac Interventions
Stentgraft Repair of Traumatic Aortic Lesions: Early and Intermediate Follow-Up
Hüseyin Ince, MD
Interventional Repair of Non-Infarct Coarctation: The IRONIC Concept with Two-Year Follow-Up
Christoph Nienaber, MD, PhD
Patient Specific Solutions for Aortic Arch Pathologies
Friedrich-W. Mohr, MD, PhD
Endoluminal vs. Open Treatment of AAA: A Real World Overview
Edward B. Diethrich, MD
New Technical Aspects for the Endovascular Treatment of Total Occlusions in the Pelvic Area
Jörn Balzer, MD, PhD
Japanese Session
Pre-Drug Eluting Stent Debulking of Bifurcated Coronary Lesions
Etsuo Tsuchikane, MD
New Devices for Retrograde Approaches to Coronary CTOs
Osamu Katoh, MD
Effect of Fluvastatin on Progression of Coronary Atherosclerotic Plaque Evaluated by Intravascular Ultrasound Virtual Histology™
Kenya Nasu, MD
Bilateral Approach to Chronic Total Occlusion: Acute Results and Follow-Up (CART Registry)
Masashi Kimura, MD, PhD
Diagnostic Accuracy of Coronary In-Stent Restenosis Using 64-Slice Computed Tomography: Comparison with Invasive Coronary Angiography
Mariko Ehara, MD
Why IVUS Improves the Outcome of Sirolimus Eluting Stent
Yuji Ikari, MD
top
Program 9
Korean Session
IVUS Guided Unprotected LMCA Intervention: Transit of Optimal Criteria to Protect TLR from BMS to DES
Myeong-Ki Hong, MD
Evaluation of Late Stent Thrombosis After DES vs. BMS Implantation in Real-Practice
Joo-Young Yang, MD
Plaque Characterization Using Multiple Imaging Modalities: Invasive Imaging Technology IVUS, VH-IVUS and OCT
Myeong-Ki Hong, MD
Left Main vs. Non-Left Main Bifurcation Stenting in the DES Era
Myeong-Ki Hong, MD
Multi-Slice CT Session:
MSCT Coronary Angiography
MSCT Basic Principles
Pim J. de Feyter, MD
How-To Read CT
Robert S. Schwartz, MD
Cardiac CT: Radiation Exposure
Augusto D. Pichard, MD
Coronary Calcium: Prognostic Significance and Clinical Paradigm
John McB. Hodgson, MD
CTA is One-Stop Shopping: Anatomy, Function and Now Perfusion
Albert Lardo, PhD
CTA Characterization of Atherosclerotic Plaque Correlation with IVUS Update on the ATLANTA Study
Szilard Voros, MD
CT Peripheral Angiography: Do We Still Need Conventional Angios?
Jörn Balzer, MD, PhD
top
Program 10
Multi-Slice CT Session (continued)
MSCT and IVUS Correlations: Preliminary Observations
Augusto D. Pichard, MD
CT-Post Stent/CABG Evaluation
Nico R.A. Mollet, MD, PhD
CT-CTO/Navigation, Guiding
Pim J. de Feyter, MD
LV-Function, Infarct Size, Viability
Robert S. Schwartz, MD
Assessment of Chest Pain in the Emergency Department by Computed Tomography
Gilbert L. Raff, MD
German Session
Computer Enhanced Robotic Surgery – Where are we Now?
Friedrich-W. Mohr, MD, PhD
New Techniques for PFO and ASD Closure
Horst Sievert, MD
Percutaneous Technique to Create AV-Shunts
Horst Sievert, MD
Report of European CTO Club on State-of-the-Art of CTO Treatment Outside Japan
Nicolaus Reifart, MD
Results of Second Generation DES on Efficacy and Safety
Hans Störger, MD
top
Program 11
German Session (continued)
Bifurcation DES
Karl-Eugen Hauptmann, MD
Microemboli During PCI: How Frequent Are They (really), and What is Their Significance?
Gerald Werner, MD
American Session V:
New Concepts and Devices II
Robotics: Do They Have a Place in Interventional Cardiology?
Daniel T. Wallace, MS
Implantable Left Atrial Pressure (LAP) Monitoring in Heart Failure: Preliminary Results of the HOMEOSTASIS Trials
Neal Eigler, MD
Peripheral Session II:
Infra-Inguinal Interventions
Local Taxan with Short Time Contact for Reduction of Restenosis in Distal Arteries, 12 – Months Data: THUNDERTrial
Gunnar Tepe, MD
6-Months After Treatment of Total SFA Occlusions (TASC C and D): Data of the RIO Trial
Gunnar Tepe, MD
Stem Cells in Critical Limb Ischemia: The PROVASA Study
Hans Krankenberg, MD
Technical Aspects in the Treatment of Complex Tibial Obstructions in CLI
Thomas Zeller, MD
Dutch Session
AMC TRIAS Pilot Results RCT Genous vs. TAXUS: Long-term Clinical Results
R.J. de Winter, MD, PhD
Thrombectomy in Primary PCI: The AMC Registry Histology and Long-term Outcome of >1300 Patients Undergoing Primary PCI and Thrombectomy
Karel T. Koch, MD, PhD
Autologous Stem Cell Infusion After Acute MI: Invasive Follow-Up Techniques
Pim Tonino, MD
Drug Eluting Stents in Acute Myocardial Infarction
M. Quéré, MD
top
Program 12
Dutch Session (continued)
Platelet Reactivity in Patients with Previous Stent Thrombosis
J.M. ten Berg, MD, PhD
Our Clinical Experience with the Retrograde CTO Approach 2007
Jacques J. Koolen, MD, PhD
Non-Culprit Lesions Detected During Primary PCI: Treat Invasively or Follow the Guidelines?
Jan-Henk E. Dambrink, MD, PhD
OPTIMA: Optimal Timing of PCI in Non-STE-ACS
Gert-Jan Laarman, MD, PhD
Pre-hospital Triage in STEMI: “The Amsterdam Experience”
Yolande Appelman, MD, PhD
Reduction of Reperfusion Damage in Acute MI
Pieter Doevendans, MD, PhD
The MELISSA I Study
Guus Brueren, MD
COURAGE: In the Eye of the Beholder
Dean A. Bramlet, MD
Peripheral Session III:
New Strategy for Peripheral Interventions: How to Improve Limping Guidelines to Prevent Patients’ Hobbling?
Do We Need New Guidelines for Diagnosis and Treatment of PAD
Pawel Buszman, MD
Advances in SFA Stenting
Stanislaw Bartus, MD
top
Program 13
Peripheral Session III (continued)
Balloon Angioplasty and Stenting vs. Plaque Removal for Peripheral Intervention
R. Stefan Kiesz, MD
Orbital Atherectomy for the Treatment of Critical Limb Ischemia
Richard R. Heuser, MD
Peripheral Session IV: Carotid Stenting
Technical Improvements in the Armamentarium for Carotid Artery Stenting: Are They Really Improvements?
Horst Sievert, MD
Where are we Going with CAS: Expectations, Actual Reality and Future
Giancarlo Biamino, MD, PhD
top
